Lexaria raises $3.5M in registered direct offering with warrants

Lexaria Bioscience Corp.

Issued 2,661,600 shares at $1.315/share, gross proceeds ~$3.5M.
Concurrent private placement of warrants for 2,661,600 shares at $1.19 exercise price, 5-year term.
H.C. Wainwright acted as exclusive placement agent; fees 7% cash plus 93,156 placement agent warrants at $1.6438.
Net proceeds to fund R&D, working capital, and general corporate purposes.
Offering closed on December 16, 2025; shares registered under Form S-3, warrants unregistered.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.